Nan Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nan Jia has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Richard D. Cummings
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
5 shared publications - Chao Gao
Harvard Medical School Center for Glycoscience, National Center for Functional Glycomics, Beth Israel Deaconess Medical Center , 330 Brookline Avenue, Boston, MA 02215, USA
2 shared publications - David A. Steinhauer
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA.
2 shared publications - Lauren Byrd-Leotis
Department of Microbiology and Immunology, Emory University School of Medicine Atlanta, GA, 30322, USA; Centers for Excellence in Influenza Research and Surveillance, Emory-UGA CEIRS, Atlanta, GA, 30322, USA
2 shared publications Yasuyuki Matsumoto
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
2 shared publications- Akul Y. Mehta
Department of Surgery, Beth Israel Deaconess Medical Center, National Center for Functional Glycomics, Harvard Medical School , CLS 11087-3 Blackfan Circle, Boston, Massachusetts 02115
1 shared publication
Latest Publications
- 2 January 2025
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (1) , 49-62
Development and validation of an ultrasensitive qPCR method to identify and quantify EGFR T790M in cell-free DNA
Circulating tumor DNA (ctDNA) is a promising biomarker for cancer prognosis and drug development. A major challenge in the ctDNA determination method is discriminating ctDNA from highly similar but significantly more abundant wild-type DNA sensitively and accurately. An ultrasensitive qPCR method termed Triple Enrichment Amplification of Mutation PCR (TEAM-PCR) was developed to detect EGFR T790M mutation. EGFR T790M was quantified over the assay range of 25-106 copies/reaction in the presence of 106 wild-type copies. This method was fully validated following the essential bioanalysis guidance, with the limit of detection (LOD) being five copies/reaction. This study established and validated a qPCR-based strategy to detect EGFR T790M mutation with ultra-high sensitivity and reliability.
- 2 January 2025
- Published by Taylor & Francis in Bioanalysis
- Vol. 17 (1) , 49-62
Development and validation of an ultrasensitive qPCR method to identify and quantify EGFR T790M in cell-free DNA
Circulating tumor DNA (ctDNA) is a promising biomarker for cancer prognosis and drug development. A major challenge in the ctDNA determination method is discriminating ctDNA from highly similar but significantly more abundant wild-type DNA sensitively and accurately. An ultrasensitive qPCR method termed Triple Enrichment Amplification of Mutation PCR (TEAM-PCR) was developed to detect EGFR T790M mutation. EGFR T790M was quantified over the assay range of 25-106 copies/reaction in the presence of 106 wild-type copies. This method was fully validated following the essential bioanalysis guidance, with the limit of detection (LOD) being five copies/reaction. This study established and validated a qPCR-based strategy to detect EGFR T790M mutation with ultra-high sensitivity and reliability.
- Open Access
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabf6834
Differential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity
The recognition of oligomannose-type glycans in innate and adaptive immunity is elusive due to multiple closely related isomeric glycan structures. To explore the functions of oligomannoses, we developed a multifaceted approach combining mass spectrometry assignments of oligomannose substructures and the development of a comprehensive oligomannose microarray. This defined microarray encompasses both linear and branched glycans, varying in linkages, branching patterns, and phosphorylation status. With this resource, we identified unique recognition of oligomannose motifs by innate immune receptors, including DC-SIGN, L-SIGN, Dectin-2, and Langerin, broadly neutralizing antibodies against HIV gp120, N-acetylglucosamine-1-phosphotransferase, and the bacterial adhesin FimH. The results demonstrate that each protein exhibits a unique specificity to oligomannose motifs and suggest the potential to rationally design inhibitors to selectively block these protein-glycan interactions.
- 11 June 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (24) , eabf6834
Open AccessDifferential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity
The recognition of oligomannose-type glycans in innate and adaptive immunity is elusive due to multiple closely related isomeric glycan structures. To explore the functions of oligomannoses, we developed a multifaceted approach combining mass spectrometry assignments of oligomannose substructures and the development of a comprehensive oligomannose microarray. This defined microarray encompasses both linear and branched glycans, varying in linkages, branching patterns, and phosphorylation status. With this resource, we identified unique recognition of oligomannose motifs by innate immune receptors, including DC-SIGN, L-SIGN, Dectin-2, and Langerin, broadly neutralizing antibodies against HIV gp120, N-acetylglucosamine-1-phosphotransferase, and the bacterial adhesin FimH. The results demonstrate that each protein exhibits a unique specificity to oligomannose motifs and suggest the potential to rationally design inhibitors to selectively block these protein-glycan interactions.
- 1 April 2021
- Published by Elsevier in Cell Chemical Biology
- Vol. 28 (4) , 567-582.e4
Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteins
- 1 April 2021
- Published by Elsevier in Cell Chemical Biology
- Vol. 28 (4) , 567-582.e4
Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteins
- Open Access
- 24 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
The Human Lung Glycome Reveals Novel Glycan Ligands for Influenza A Virus
Glycans within human lungs are recognized by many pathogens such as influenza A virus (IAV), yet little is known about their structures. Here we present the first analysis of the N- and O- and glycosphingolipid-glycans from total human lungs, along with histological analyses of IAV binding. The N-glycome of human lung contains extremely large complex-type N-glycans with linear poly-N-acetyllactosamine (PL) [-3Galβ1–4GlcNAcβ1-]n extensions, which are predominantly terminated in α2,3-linked sialic acid. By contrast, smaller N-glycans lack PL and are enriched in α2,6-linked sialic acids. In addition, we observed large glycosphingolipid (GSL)-glycans, which also consists of linear PL, terminating in mainly α2,3-linked sialic acid. Histological staining revealed that IAV binds to sialylated and non-sialylated glycans and binding is not concordant with respect to binding by sialic acid-specific lectins. These results extend our understanding of the types of glycans that may serve as binding sites for human lung pathogens.
- 24 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Open AccessThe Human Lung Glycome Reveals Novel Glycan Ligands for Influenza A Virus
Glycans within human lungs are recognized by many pathogens such as influenza A virus (IAV), yet little is known about their structures. Here we present the first analysis of the N- and O- and glycosphingolipid-glycans from total human lungs, along with histological analyses of IAV binding. The N-glycome of human lung contains extremely large complex-type N-glycans with linear poly-N-acetyllactosamine (PL) [-3Galβ1–4GlcNAcβ1-]n extensions, which are predominantly terminated in α2,3-linked sialic acid. By contrast, smaller N-glycans lack PL and are enriched in α2,6-linked sialic acids. In addition, we observed large glycosphingolipid (GSL)-glycans, which also consists of linear PL, terminating in mainly α2,3-linked sialic acid. Histological staining revealed that IAV binds to sialylated and non-sialylated glycans and binding is not concordant with respect to binding by sialic acid-specific lectins. These results extend our understanding of the types of glycans that may serve as binding sites for human lung pathogens.
- Open Access
- 1 February 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (2) , eaav2554
Influenza binds phosphorylated glycans from human lung
A novel array of human lung glycans reveals influenza A virus binding to phosphorylated as well as sialylated N-glycans.
- 1 February 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (2) , eaav2554
Open AccessInfluenza binds phosphorylated glycans from human lung
A novel array of human lung glycans reveals influenza A virus binding to phosphorylated as well as sialylated N-glycans.
- Open Access
- 11 May 2018
- Published by Wiley in Arthritis & Rheumatology
- Vol. 70 (7) , 1102-1113
Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N‐Glycosylation in Antibody‐Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren’s Syndrome
Objective: To better understand the role of B cells, the potential mechanisms responsible for their aberrant activation, and the production of autoantibodies in the pathogenesis of Sjögren's syndrome (SS), this study explored patterns of selection pressure and sites of N‐glycosylation acquired by somatic mutation (acN‐glyc) in the IgG variable (V) regions of antibody‐secreting cells (ASCs) isolated from the minor salivary glands of patients with SS and non‐SS control patients with sicca symptoms.Methods: A novel method to produce and characterize recombinant monoclonal antibodies (mAb) from single cell–sorted ASC infiltrates was applied to concurrently probe expressed genes (all heavy‐ and light‐chain isotypes as well as any other gene of interest not related to immunoglobulin) in the labial salivary glands of patients with SS and non‐SS controls. V regions were amplified by reverse transcription–polymerase chain reaction, sequenced, and analyzed for the incidence of N‐glycosylation and selection pressure. For specificity testing, the amplified regions were expressed as either the native mAb or mutant mAb lacking the acN‐glyc motif. Protein modeling was used to demonstrate how even an acN‐glyc site outside of the complementarity‐determining region could participate in, or inhibit, antigen binding.Results: V‐region sequence analyses revealed clonal expansions and evidence of secondary light‐chain editing and allelic inclusion, of which neither of the latter two have previously been reported in patients with SS. Increased frequencies of acN‐glyc were found in the sequences from patients with SS, and these acN‐glyc regions were associated with an increased number of replacement mutations and lowered selection pressure. A clonal set of polyreactive mAb with differential framework region 1 acN‐glyc motifs was also identified, and removal of the acN‐glyc could nearly abolish binding to autoantigens.Conclusion: These findings support the notion of an alternative mechanism for the selection and proliferation of some autoreactive B cells, involving V‐region N‐glycosylation, in patients with SS.
- 11 May 2018
- Published by Wiley in Arthritis & Rheumatology
- Vol. 70 (7) , 1102-1113
Open AccessEvidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N‐Glycosylation in Antibody‐Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren’s Syndrome
Objective: To better understand the role of B cells, the potential mechanisms responsible for their aberrant activation, and the production of autoantibodies in the pathogenesis of Sjögren's syndrome (SS), this study explored patterns of selection pressure and sites of N‐glycosylation acquired by somatic mutation (acN‐glyc) in the IgG variable (V) regions of antibody‐secreting cells (ASCs) isolated from the minor salivary glands of patients with SS and non‐SS control patients with sicca symptoms.Methods: A novel method to produce and characterize recombinant monoclonal antibodies (mAb) from single cell–sorted ASC infiltrates was applied to concurrently probe expressed genes (all heavy‐ and light‐chain isotypes as well as any other gene of interest not related to immunoglobulin) in the labial salivary glands of patients with SS and non‐SS controls. V regions were amplified by reverse transcription–polymerase chain reaction, sequenced, and analyzed for the incidence of N‐glycosylation and selection pressure. For specificity testing, the amplified regions were expressed as either the native mAb or mutant mAb lacking the acN‐glyc motif. Protein modeling was used to demonstrate how even an acN‐glyc site outside of the complementarity‐determining region could participate in, or inhibit, antigen binding.Results: V‐region sequence analyses revealed clonal expansions and evidence of secondary light‐chain editing and allelic inclusion, of which neither of the latter two have previously been reported in patients with SS. Increased frequencies of acN‐glyc were found in the sequences from patients with SS, and these acN‐glyc regions were associated with an increased number of replacement mutations and lowered selection pressure. A clonal set of polyreactive mAb with differential framework region 1 acN‐glyc motifs was also identified, and removal of the acN‐glyc could nearly abolish binding to autoantigens.Conclusion: These findings support the notion of an alternative mechanism for the selection and proliferation of some autoreactive B cells, involving V‐region N‐glycosylation, in patients with SS.